Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.10
0.00 (0.00%)
At close: Jan 23, 2026

HKG:3378 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Cash & Equivalents
161.21162
Short-Term Investments
12.6742.36
Cash & Short-Term Investments
173.88204.36
Cash Growth
-14.92%-
Prepaid Expenses
68.9193.9
Other Current Assets
-0.5
Total Current Assets
242.79298.76
Property, Plant & Equipment
24.1324
Long-Term Investments
233.78262.39
Other Intangible Assets
0.450.56
Other Long-Term Assets
0.330.53
Total Assets
501.47586.24
Accounts Payable
12.2912.94
Accrued Expenses
2.82.56
Current Portion of Leases
3.173.2
Current Income Taxes Payable
7.987.07
Other Current Liabilities
171.237.11
Total Current Liabilities
197.4462.87
Long-Term Leases
8.6611.83
Long-Term Deferred Tax Liabilities
78.7790.47
Other Long-Term Liabilities
-101.49
Total Liabilities
284.87266.66
Common Stock
11.799.53
Retained Earnings
-72.380.53
Comprehensive Income & Other
226.83258.07
Total Common Equity
166.24268.13
Minority Interest
50.3751.45
Shareholders' Equity
216.6319.58
Total Liabilities & Equity
501.47586.24
Total Debt
11.8315.03
Net Cash (Debt)
162.05189.33
Net Cash Growth
-14.41%-
Net Cash Per Share
14.8225.95
Filing Date Shares Outstanding
11.797.3
Total Common Shares Outstanding
11.797.3
Working Capital
45.35235.89
Book Value Per Share
14.1036.75
Tangible Book Value
165.79267.57
Tangible Book Value Per Share
14.0636.68
Machinery
5.144.1
Construction In Progress
2.666.41
Leasehold Improvements
8.2-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.